Dynamic metabolic reprogramming in dendritic cells: an early response to influenza infection that is essential for effector function

Infection with the influenza virus triggers an innate immune response aimed at initiating the adaptive response to halt viral replication and spread. However, the metabolic response fueling the molecular mechanisms underlying changes in innate immune cell homeostasis remain undefined. Thus, we compared the metabolic response of dendritic cells to that of those infected with active and inactive influenza A virus or treated with toll like receptor agonists. While influenza infects dendritic cells, it does not productively replicate in these cells, and therefore metabolic changes upon infection may represent an adaptive response on the part of the host cells. Using quantitative mass spectrometry along with pulse chase substrate utilization assays and metabolic flux measurements, we found global metabolic changes 17 hours post infection, including significant changes in carbon commitment via glycolysis and glutaminolysis, as well as ATP production via TCA cycle and oxidative phosphorylation. Influenza infection of dendritic cells led to a metabolic phenotype, distinct from that induced by TLR agonists, with significant resilience in terms of metabolic plasticity. We identified Myc as one transcription factor modulating this response. Restriction of either Myc activity or mitochondrial substrates resulted in significant changes in the innate immune functions of dendritic cells, including reduced motility and T cell activation. Transcriptome analysis of inflammatory dendritic cells isolated following influenza infection showed similar metabolic reprogramming occurs in vivo. Thus, early in the infection process dendritic cells respond with global metabolic restructuring that is present in lung DC 9 days following infection and impacts their effector function, suggesting that metabolic switching in dendritic cells plays a vital role in initiating the immune response to influenza infection. Author SummaryIn response to influenza infection we found that dendritic cells, cells that are critical in mounting an effective immune response, undergo a profound metabolic shift. They alter the concentration and location of hundreds of proteins, including c-MYC, mediating a shift to a highly glycolytic phenotype that is also flexible in terms of fueling respiration. Dendritic cells initiate the immune response to influenza and activate the adaptive response allowing viral clearance and manifesting immune memory for protection against subsequent infections. We found that limiting access to specific metabolic pathways or substrates diminished key immune functions. Previously we described an immediate, fixed, hypermetabolic state in infected respiratory epithelial cells. We now show the metabolic responses of epithelial and dendritic cells are distinct. Here, we also demonstrate that dendritic cells tailor their metabolic response to the pathogen or TLR stimulus. This metabolic reprogramming occurs rapidly in vitro and it is sustained in inflammatory dendritic cells in vivo for at least 9 days following influenza infection. Thus, drugs targeting metabolism are likely to have cell- and pathogen-specific activities in the context of infection. These studies open the possibility of modulating the immune response to viral infection via customizing metabolic therapy to enhance or diminish the function of specific cells.